Of 1258 patients with sepsis, 1124 (89%) were eligible for the study, finding that the hs-cTnI concentration was elevated in 60% of patients on day one, and 67% continually presented elevated hs-cTnI levels. This evidence concerns the gene TNNI3 and Sepsis.